Tag: pharma

The cloud has brought agility and cost savings compared to running workloads in a data center, forcing customers to consider how regulatory concerns are shared between themselves and the cloud provider. Customers with existing GxP (an abbreviation for “good practice” guidelines and regulations for various industries like pharmaceutical, agricultural, or manufacturing) solutions are challenged when […]

For customers looking to implement a GxP-compliant environment on AWS, we have released a new whitepaper: GxP Systems on AWS. Access Whitepaper This whitepaper provides essential information and guidance on building GxP-regulated systems using AWS services, and outlines how AWS approaches GxP-related compliance and security. Building on our previous GxP guidance, the content of this […]

Andrew Goldberg, Co-founder and COO of HealthVerity, joins Jared Saul, Global Head of Healthcare and Life Sciences Startups at AWS, for a discussion on industry trends shaping the way payors and pharmaceutical organizations exchange and manage data, the role of real-time data in COVD-19 vaccine development, and a vision for a flexible data strategy. HealthVerity, […]

Marcello Damiani, Chief Digital and Operational Excellence Officer at Moderna, joins Todd Weatherby, Vice President of AWS Professional Services Worldwide, for a discussion on developing Moderna’s COVID-19 vaccine, scaling systems to enable global distribution, and leveraging cloud technologies to accelerate processes. Moderna is pioneering a new class of medicines made of messenger RNA, or mRNA, […]

This article originally appeared on Accenture. Challenge Digital technologies are transforming the life sciences industry as much as advanced science. The ability to extract, analyze and visualize data quickly from across the company can help biopharmaceutical companies become intelligent enterprises and better serve patients. Bristol Myers Squibb (BMS), a global leading biopharma company, is intent […]

This article originally appeared on Wired. Disease understanding and drug discovery is based on scientific rigor. And while it’s work that is potentially life changing, it can also be tedious and time-consuming. Few know this better than Magnus Söderberg, a pathology researcher with more than 20 years of lab experience and the director and technical […]

Buying a COVID-19 vaccination on the dark web for upwards of $1000 only for it never to materialize sounds like something from a Hollywood script. But according to cybersecurity agencies like Check Point, this situation is presenting itself to patients eager for vaccinations.  Fraudulent activities like this and fake drug products such as those described […]

Ground-breaking new therapies and scientific advances in technology are driving the exponential rate of innovation in the pharmaceutical industry. With the explosion of big data and the complexity that comes with it, leaders in life sciences research and development (R&D) are adopting digital transformation to speed up discovery and maximize investments. Siping “Spin” Wang, President […]

Guest authored by Bryan Lajoie, Staff Bioinformatics Scientist at Illumina Inc. — We are pleased to announce the release of a comprehensive reanalysis of 3,202 deeply-sequenced samples from the 1000 Genomes Project(1kGP) using the Illumina DRAGEN (Dynamic Read Analysis for GENomics) Bio-IT platform. This seminal dataset will be freely available for researchers across the world to use […]

Introduction Bio-pharmaceutical companies have always had a responsibility to report adverse events (AE), whether in clinical development or post market-approval scenarios, to the Food and Drug Administration (FDA).  The COVID-19 pandemic and the race to find effective treatments for this disease has caused both the FDA and bio-pharmaceutical organizations around the world to re-imagine the […]